In addition, the GLP-1 agonists may make some drugs more aversive or unpleasant, says Luba Yammine, an associate professor of psychiatry at UTHealth Houston who is currently the principal investigator of a clinical trial evaluating a GLP-1 agonist as a potential treatment for smoking cessation and post-cessation weight management
In fact, a multimodal approach often produces the best outcomes for PCOS
In the pivotal SURPASS clinical trials evaluating tirzepatide for type 2 diabetes, and the SURMOUNT trials for weight management, sweating or hyperhidrosis was not reported among the adverse events occurring with notable frequency
Review on plant antimicrobials: a mechanistic viewpoint
It has been shown that in the brains of patients with AD or PD, insulin signaling can be impaired [19,20,21,22,23]